PATENT CLAIM ANALYSIS

Application Number: 15947820
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "190100"]

Abstract:
This invention describes novel adjuvant compositions and formulations with excellent stability at refrigerated and room temperatures and up to and about 37° C. that can be produced at remarkably low costs. This invention describes novel vaccine compositions and formulations to treat and prevent urinary tract infections caused by gram-negative bacteria including  Escherichia coli  and multi-drug resistant  E. coli . This invention also describes methods of administration of said novel vaccine compositions and formulations and methods of treatment to prevent and treat urinary tract infections caused by gram-negative bacteria including  E. coli  and multi-drug resistant  E. coli.

Claim (Index 52):
The method of  claim 49 , wherein the vaccine comprises less than 30 mM of NaCl and phosphatidylcholine.

Metadata:
- Claim Count in Document: 98.0
- Percentile: 91.0
- Lexical Diversity: 1.96
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15727615', '14660523', '14663690', '15130720', '15295287']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.84481420022271
- 35 USC 102 Novelty (BERT): 0.6243557605066369
- Combined Prediction Score: 0.8227683562511028
- Mean Citation Score: 598.0033559999998
- Max Citation Score: 620.15393
- Similarity Product: 525.8169679611783

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test